Stamford, CT -- (SBWIRE) -- 12/20/2013 -- High Rising Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: ImmunoCellular Therapeutics Ltd(NYSEMKT:IMUC), LIGHTSTREAM RES(OTCMKTS:LSTMF), Annaly Capital Management, Inc.(NYSE:NLY), Novavax, Inc.(NASDAQ:NVAX)
ImmunoCellular Therapeutics Ltd(NYSEMKT:IMUC) opened the session at $0.71, remained amid the day range of $0.69 - $0.80, and closed the session at $0.721. The stock showed a negative performance of -2.49% in previous trading session. The stock gained a volume of 3.38 million shares and the average volume of the stock remained 3.14 million shares. ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, engages in developing and commercializing immune-based therapies for the treatment of brain, ovarian, and other solid tumors.
Will IMUC Get Buyers Even After The Recent Rally? Find Out Here
LIGHTSTREAM RES(OTCMKTS:LSTMF) traded with volume of 450,831.00 shares in the prior session and the average volume of the stock remained 267,129.00 shares. The 52 week range of the stock remained $4.75 - $8.65. The stock showed a negative movement of -0.77% and closed its session at $5.13. The market capitalization of the stock remained 1.03 billion. Lightstream Resources Ltd. operates as an oil and gas exploration and production company focusing on light oil Bakken and Cardium resource plays with conventional light oil assets in Canada.
Why Should Investors Buy LSTMF After the Recent Fall? Just Go Here and Find Out
Annaly Capital Management, Inc.(NYSE:NLY) exchanged 29.22 million shares and the average volume remained 15.97 million shares. The stock dropped -3.42% and closed the session at $9.87. The beta of the stock remained 0.31 and the EPS of the stock remained 3.35. The shares outstanding of the stock remained 947.40 million. Annaly Capital Management, Inc. owns, manages, and finances a portfolio of real estate related investments in United States.
Has NLY Found The Bottom And Ready To Gain Momentum? Find Out Here
Novavax, Inc.(NASDAQ:NVAX) gained volume of 6.40 million shares, while the average volume remained 4.83 million shares. The stock advanced +3.77% and finished the session Thursday at $4.68. The EPS of the stock remained -0.30. The one month of the stock was 49.04% and three month trend remained positive 48.57%. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases.
For How Long NVAX’s Gloss will Attract Investors ? Find out via this report
High Rising Stocks provides investors with the hottest penny stock alerts on a regular basis. It carries Hot Penny Stocks and Penny Stock Newsletter, we will send you alerts through our Free Penny Stock Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)